Navigate Ongoing COVID-19 Vaccine Changes

You’ll need to stay on top of changing COVID-19 vaccine guidance...now that monovalent mRNA products are no longer authorized.

Only about 17% of people in the US have had a bivalent dose.

Acknowledge that overall vaccine efficacy wanes over time and most patients have had COVID-19...making data challenging to interpret.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote